Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
NCT ID: NCT00457587
Last Updated: 2025-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
150 participants
OBSERVATIONAL
2005-09-30
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma
NCT00576641
Tumor-specific T Cells in Lung Cancer
NCT02515760
Dendritic Cell Vaccination for Patients with Solid Tumors
NCT01291420
Phase I Study of Anti-CD22 Chimeric Receptor T Cells in Patients With Relapsed/Refractory Hairy Cell Leukemia and Variant
NCT04815356
MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer
NCT04078269
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* healthy persons as control group
* Life expectancy \> 6 months
Exclusion Criteria
* severe clinical condition
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Deutsche Krebshilfe e.V., Bonn (Germany)
OTHER
University of Wuerzburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Martin Fassnacht
Professor for Internal Medicine and Endocrinology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martin Fassnacht, MD
Role: PRINCIPAL_INVESTIGATOR
University of Wuerzburg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. of Medicine I, University of Wuerzburg
Würzburg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Landwehr LS, Altieri B, Schreiner J, Sbiera I, Weigand I, Kroiss M, Fassnacht M, Sbiera S. Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma. J Immunother Cancer. 2020 May;8(1):e000469. doi: 10.1136/jitc-2019-000469.
Related Links
Access external resources that provide additional context or updates about the study.
Homepage Dept. of Endocrinology, U Wuerzburg
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Wue-Immuno-ACC-83/05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.